Literature DB >> 16974106

Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene.

V Herzovich1, E Vaiani, R Marino, G Dratler, J M Lazzati, S Tilitzky, P Ramirez, S Iorcansky, M A Rivarola, A Belgorosky.   

Abstract

The specific thyroid hormone transporter, MCT8, located on the X chromosome, has led to the identification a novel syndrome. The objective is to relate phenotype with several tissue-specific thyroid functions. A 1-year-old boy, who had severe psychological damage and low serum T4, had received l-T4 for 3 months. At admission, body length was normal but weight was low. Off therapy, serum TSH was mildly elevated, serum T4 and free T4 were low, and serum T3 and free T3 were high. Direct sequencing of the MCT8 gene revealed a single nucleotide change that resulted in a novel nonsense mutation at codon 261 (Q261X) in exon 3. Since serum T3 was high, peripheral markers of hyperthyroidism were looked for. Bone age was advanced, despite the presence of malnutrition and low T4. Serum SHBG, a marker of thyroid hormone action in liver, was markedly elevated. Markers of skeletal muscle catabolism, ammonemia and lactic acid, were found to be elevated. The phenotype of MCT 8 mutation might be explained by differences in the entry of thyroid hormones into different cells. In the presence of an inactive MCT8 transporter, the high blood T3 levels might not be enough to prevent brain damage early in life, while they seem to be able to induce a postnatal state of peripheral hyperthyroidism in other tissues, such as liver, bone and skeletal muscle. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16974106     DOI: 10.1159/000095805

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  23 in total

1.  Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum T3 levels.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Honggang Ye; Alfonso Massimiliano Ferrara; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

2.  Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.

Authors:  Soledad Bárez-López; Meredith D Hartley; Carmen Grijota-Martínez; Thomas S Scanlan; Ana Guadaño-Ferraz
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

Review 3.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

4.  Understanding the hypothalamus-pituitary-thyroid axis in mct8 deficiency.

Authors:  Julia Müller; Heike Heuer
Journal:  Eur Thyroid J       Date:  2012-06-20

Review 5.  The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.

Authors:  Charles E Schwartz; Roger E Stevenson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

6.  Elevated TSH levels in a mentally retarded boy.

Authors:  Ellen Crushell; William Reardon
Journal:  Eur J Pediatr       Date:  2010-05       Impact factor: 3.183

7.  A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Alexandra M Dumitrescu; Roy E Weiss; Samuel Refetoff
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

8.  Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.

Authors:  Edith C H Friesema; Jurgen Jansen; Jan-Willem Jachtenberg; W Edward Visser; Monique H A Kester; Theo J Visser
Journal:  Mol Endocrinol       Date:  2008-03-12

Review 9.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

10.  White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene.

Authors:  Artemis D Gika; Ata Siddiqui; Anthony J Hulse; Selvakumari Edward; Penny Fallon; Meriel E McEntagart; Wajanat Jan; Dragana Josifova; Tally Lerman-Sagie; James Drummond; Edward Thompson; Samuel Refetoff; Carsten G Bönnemann; Heinz Jungbluth
Journal:  Dev Med Child Neurol       Date:  2009-10-07       Impact factor: 5.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.